About this trial
The purpose of this study is to evaluate the safety, feasibility, and preliminary effectiveness of the ReWire system, which delivers vagus nerve stimulation (VNS) paired with lower limb rehabilitation to improve gait in individuals with mobility impairments resulting from chronic, incomplete spinal cord injury (SCI).
Eligibility criteria
Qualifiers
Ability to provide signed and dated informed consent.
Willingness and ability to comply with all study procedures and protocol requirements for the duration of the study.
Age 18 to 64 years.
Chronic, non-penetrating, motor incomplete spinal cord injury [Association Impairment Scale (AIS) grade C or D] occurring ≥12 months prior to enrollment, resulting in impairment in lower limb function.
Disqualifiers
Any history of spinal cord injuries by penetrating traumatic, non-traumatic or congenital causes.
Evidence of right-sided recurrent laryngeal nerve injury on pre-operative laryngoscopy, if required (Note: Participants with a history of right-sided anterior cervical surgery must undergo laryngoscopy prior to surgical scheduling. A finding of right-sided recurrent laryngeal nerve injury results in exclusion).
Excessive scar tissue on intraoperative assessment that precludes safe implantation (Note: Participants with a history of left-sided anterior cervical surgery will undergo intraoperative assessment of scar tissue. If excessive scar tissue is deemed to preclude safe implantation, the procedure will be abandoned and the participant excluded for safety reasons. A history of left-sided anterior cervical surgery or prior recurrent laryngeal nerve injury alone does not result in exclusion).
Concomitant clinically significant brain injuries.
Trial design
Treatments tested in this trial
- CLV
- Sham
Treatment groups
Sponsors and collaborators
The University of Texas at Dallas
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator